Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions-Reference-Cited by-同舟云学术

Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions

Published:2016 Issue:25 Volume:8 Page:12544-12552
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Leonard Fransisca¹²³,Curtis Louis T.⁴⁵⁶,Yesantharao Pooja¹²³,Tanei Tomonori¹²³,Alexander Jenolyn F.¹²³,Wu Min⁷⁸⁹,Lowengrub John¹⁰¹¹¹²¹³,Liu Xuewu¹²³,Ferrari Mauro¹²³,Yokoi Kenji¹²³,Frieboes Hermann B.⁴⁵⁶,Godin Biana¹²³

Affiliation:

1. Houston Methodist Research Institute

2. Department of Nanomedicine

3. R8-213, Houston, USA

4. University of Louisville

5. Department of Bioengineering

6. Louisville, USA

7. Northwestern University

8. Department of Engineering Sciences and Applied Mathematics

9. Chicago, USA

10. University of California

11. Irvine

12. Department of Mathematics

13. Irvine, USA

Abstract

The proposed experimental/computational approach could enable prediction of nanotherapeutics performance to treat hypovascularized metastatic cancer in the liver.

Funder

National Science Foundation

National Institutes of Health

National Cancer Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2016/NR/C5NR07796F

Reference49 articles.

1. Liver metastases from breast cancer: Long-term survival after curative resection☆